Clinical Trial Update: Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs [NA]

View source ↗

Summary

A study protocol investigating the impact of metamizole (Optalgin) on Anti-Xa concentrations in oncology patients who are receiving direct oral anticoagulants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Coagulation Disorders

Drugs mentioned

• Optalgin (Metamizole)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Oncologic Diseases, Coagulation Defect | NA | Status: RECRUITING